Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PAX4 loss of function alters human endocrine cell development and influences diabetes risk.

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE203265 | GEO | 2023/08/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

PAX4 loss of function alters human endocrine cell development and influences diabetes risk [dataset 2]

Project description:Diabetes is a major chronic disease with an excessive healthcare burden on society. A coding variant (p.Arg192His) in the transcription factor PAX4 is uniquely and reproducibly associated with altered risk for type 2 diabetes (T2D) in East Asian populations, whilst rare PAX4 alleles have been proposed to cause monogenic diabetes8. In mice, Pax4 is essential for beta cell formation but neither the role of diabetes-associated variants in PAX4 nor PAX4 itself on human beta cell development and/or function are known. Here, we demonstrate that non-diabetic carriers of either the PAX4 p.Arg192His or a newly identified p.Tyr186X allele exhibit decreased pancreatic beta cell function. In the human beta cell model, EndoC-βH1, PAX4 knockdown led to impaired insulin secretion, reduced total insulin content and altered hormone gene expression. Deletion of PAX4 in isogenic human induced pluripotent stem cell (hiPSC)-derived beta-like cells resulted in de-repression of alpha cell gene expression whilst in vitro differentiation of hiPSCs from carriers of PAX4 p.192His and p.186X alleles exhibited increased polyhormonal endocrine cell formation and reduced insulin content. In silico and in vitro studies showed that these PAX4 alleles cause either reduced PAX4 expression or function. Correction of the diabetes-associated PAX4 alleles reversed these phenotypic changes. Together, we demonstrate the role of PAX4 in human endocrine cell development, beta cell function and its contribution to type 2 diabetes risk.

2023-08-05 | GSE203264 | GEO

PAX4 loss of function alters human endocrine cell development and influences diabetes risk [dateset 1]

2023-08-05 | GSE202206 | GEO

PAX4 loss of function alters human endocrine cell development and influences diabetes risk.

Project description:PAX4 loss of function alters human endocrine cell development and influences diabetes risk.

| PRJNA839330 | ENA

PAX4 loss of function alters human endocrine cell development and influences diabetes risk [dataset 2]

Project description:PAX4 loss of function alters human endocrine cell development and influences diabetes risk [dataset 2]

| PRJNA839336 | ENA

PAX4 loss of function alters human endocrine cell development and influences diabetes risk [dateset 1]

Project description:PAX4 loss of function alters human endocrine cell development and influences diabetes risk [dateset 1]

| PRJNA835054 | ENA

Loss of Asxl1 Alters Mesenchymal Stem Cell Fate through H3K4me3

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-07-01 | E-GEOD-75788 | biostudies-arrayexpress

Titration of RAS alters senescent state and influences tumour initiation

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-06-11 | GSE222951 | GEO

Autoimmune demyelination alters hypothalamic transcriptome and endocrine function.

Project description:The hypothalamus is a brain structure that is deputed to maintain organism homeostasis by regulating autonomic function and hormonal production as part of the neuroendocrine system. Dysfunction in hypothalamic activity results in behavioral alterations, depression, metabolic syndromes, fatigue, and infertility. Remarkably, many of these symptoms are associated with multiple sclerosis (MS), a chronic autoimmune disorder of the central nervous system (CNS) characterized by focal demyelination, immune cell infiltration into the brain parenchyma, and neurodegeneration. Furthermore, altered hormonal levels have been documented in MS patients, suggesting the putative involvement of hypothalamic deficits in MS clinical manifestations. Yet, a systematic analysis of hypothalamic function in response to neuroinflammatory stress is still lacking. To fill this gap, here we performed a longitudinal profiling of the hypothalamic transcriptome upon experimental autoimmune encephalomyelitis (EAE)-a murine disease model recapitulating key MS phenotypes at both histopathological and molecular levels. We show that changes in gene expression connected with an anti-inflammatory response start already at pre-onset and persist along EAE progression. Altered levels of hypothalamic neuropeptides were also detected, which possibly underlie homeostatic responses to stress and aberrant feeding behaviors. Last, a thorough investigation of the principal endocrine glands highlighted defects in the main steroidogenic pathways upon disease. Collectively, our findings corroborate the central role of hypothalamic dysfunction in CNS autoimmunity.

| S-EPMC10768476 | biostudies-literature

Loss of cohesin in vivo alters adult stem cell homeostasis leading to myeloproliferative neoplasms

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-09-16 | E-GEOD-72370 | biostudies-arrayexpress

Gene expression analysis of overexpression and loss-of-function at JUMONJI30

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-08-31 | E-GEOD-51898 | biostudies-arrayexpress